Sagimet Biosciences Inc.

AI Score

0

Unlock

3.45
-0.26 (-7.13%)
At close: Mar 03, 2025, 3:59 PM
3.51
1.68%
After-hours: Mar 03, 2025, 05:31 PM EST

Sagimet Biosciences Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 75.14M 158K 56.73M 68.7M 10.21M
Short-Term Investments 19.76M 32.19M n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a
Other Long-Term Assets n/a 27K 27K 27K 27K
Receivables n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a
Other Current Assets 1.75M 386K 1.93M 36K 603K
Total Current Assets 96.65M 32.79M 58.66M 68.74M 10.81M
Property-Plant & Equipment 73K 212K 342K 194K 318K
Goodwill & Intangibles n/a n/a n/a n/a n/a
Total Long-Term Assets 73K 239K 369K 221K 345K
Total Assets 96.72M 33.03M 59.03M 68.96M 11.16M
Account Payables 186K 1.13M 761K 513K 1.2M
Deferred Revenue n/a 3.96M 1.37M 1.01M n/a
Short-Term Debt 65K 133K 124K 145K 130K
Other Current Liabilities 5.4M 4.02M 1.55M 1.25M 747K
Total Current Liabilities 5.65M 5.28M 2.44M 1.91M 2.08M
Long-Term Debt n/a 78K 224K 65K 211K
Other Long-Term Liabilities n/a 214.62M 214.63M 202.89M 134.19M
Total Long-Term Liabilities n/a 214.7M 214.85M 202.96M 134.4M
Total Liabilities 5.65M 219.98M 217.29M 204.87M 136.47M
Total Debt 65K 211K 348K 210K 341K
Common Stock 2K 1K 1K 1K 1K
Retained Earnings -249.74M -221.87M -191.37M -166.93M -155.56M
Comprehensive Income 30K -84K -214.63M -202.89M -0.00
Shareholders Equity 91.06M -186.95M -158.26M -135.91M -125.31M
Total Investments 19.76M 32.19M n/a n/a n/a